Literature DB >> 22515388

The role of allergy in severe asthma.

J L Kennedy1, P W Heymann, T A E Platts-Mills.   

Abstract

The classification of asthma to identify forms which have different contributing causes is useful for all cases in which the disease requires regular treatment, but it is essential for the management of severe asthma. Many forms of the disease can occur, and complex mixtures are not uncommon; here we artificially separated the cases into four groups: (i) inhalant allergy, (ii) fungal sensitization with or without colonization (including ABPA); (iii) severe sinusitis with or without aspirin-exacerbated respiratory disease (AERD), and (iv) non-inflammatory cases, including those associated with severe obesity and vocal cord dysfunction (VCD). The reason for focusing on these groups is because they illustrate how much the specific management depends upon correct classification. Inhalant allergy can present as chronically severe asthma. However, severe attacks of asthma requiring hospital admission can occur in cases which are generally only mild or moderate. The best recognized and probably the most common cause of these acute episodes is acute infection with a rhinovirus. Recent evidence suggests that high titre IgE, particularly to dust mite, correlates to exacerbations of asthma related to rhinovirus infection. Although it is well recognized that the fungus Aspergillus can colonize the lungs and cause severe disease, it is less well recognized that those cases may not have full criteria for diagnosis of ABPA or may involve other fungi. Identifying fungal cases is important, because treatment with imidazole antifungals can provide significant benefit. Taken together, specific treatment using allergen avoidance, immunotherapy, anti-IgE, or antifungal treatment is an important part of the successful management of severe asthma, and each of these requires correctly identifying specific sensitization.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22515388      PMCID: PMC3335737          DOI: 10.1111/j.1365-2222.2011.03944.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  77 in total

1.  Studies on the pathogenesis of staphylococcal infection. V. Purification and characterization of staphylococcal alpha hemolysin.

Authors:  K GOSHI; L E CLUFF; P S NORMAN
Journal:  Bull Johns Hopkins Hosp       Date:  1963-01

2.  Trichophyton asthma.

Authors:  Thomas A E Platts-Mills; Judith A Woodfolk
Journal:  Chest       Date:  2009-04       Impact factor: 9.410

3.  Reduction of bronchial hyperreactivity during prolonged allergen avoidance.

Authors:  T A Platts-Mills; E R Tovey; E B Mitchell; H Moszoro; P Nock; S R Wilkins
Journal:  Lancet       Date:  1982-09-25       Impact factor: 79.321

4.  Effects of steroid therapy on inflammatory cell subtypes in asthma.

Authors:  Douglas C Cowan; Jan O Cowan; Rochelle Palmay; Avis Williamson; D Robin Taylor
Journal:  Thorax       Date:  2009-12-08       Impact factor: 9.139

Review 5.  Review of clinical activity and mode of action of sodium cromoglycate.

Authors:  R E Altounyan
Journal:  Clin Allergy       Date:  1980-07

6.  Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses.

Authors:  G P Rakes; E Arruda; J M Ingram; G E Hoover; J C Zambrano; F G Hayden; T A Platts-Mills; P W Heymann
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

7.  Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.

Authors:  J M Spergel; E Mizoguchi; J P Brewer; T R Martin; A K Bhan; R S Geha
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

8.  Profound adrenal suppression secondary to treatment with low dose inhaled steroids and itraconazole in allergic bronchopulmonary aspergillosis in cystic fibrosis.

Authors:  J S Parmar; T Howell; J Kelly; D Bilton
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

9.  Exacerbations of asthma in adults during experimental rhinovirus infection.

Authors:  S A Halperin; P A Eggleston; P Beasley; P Suratt; J O Hendley; D H Gröschel; J M Gwaltney
Journal:  Am Rev Respir Dis       Date:  1985-11

10.  Airway inflammation in obese and nonobese patients with difficult-to-treat asthma.

Authors:  I H van Veen; A Ten Brinke; P J Sterk; K F Rabe; E H Bel
Journal:  Allergy       Date:  2008-05       Impact factor: 13.146

View more
  13 in total

Review 1.  IgE in the diagnosis and treatment of allergic disease.

Authors:  Thomas A E Platts-Mills; Alexander J Schuyler; Elizabeth A Erwin; Scott P Commins; Judith A Woodfolk
Journal:  J Allergy Clin Immunol       Date:  2016-04-27       Impact factor: 10.793

2.  Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children.

Authors:  David B Kantor; Nicole Stenquist; Molly C McDonald; Blake J Schultz; Marissa Hauptman; Craig D Smallwood; Kyle A Nelson; Matthew S Perzanowski; Elizabeth C Matsui; Wanda Phipatanakul; Joel N Hirschhorn
Journal:  J Allergy Clin Immunol       Date:  2016-06-15       Impact factor: 10.793

3.  Genetic polymorphisms and risk of recurrent wheezing in pediatric age.

Authors:  Susanna Esposito; Valentina Ierardi; Cristina Daleno; Alessia Scala; Leonardo Terranova; Claudia Tagliabue; Walter Peves Rios; Claudio Pelucchi; Nicola Principi
Journal:  BMC Pulm Med       Date:  2014-10-18       Impact factor: 3.317

4.  Ex vivo modulation of the Foxo1 phosphorylation state does not lead to dysfunction of T regulatory cells.

Authors:  Kristen Kelley Penberthy; Monica Weaver Buckley; Sanja Arandjelovic; Kodi Ravichandran
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

5.  Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice.

Authors:  Jorge L Medina; Edward G Brooks; Adriana Chaparro; Peter H Dube
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

Review 6.  Is allergic sensitization relevant in severe asthma? Which allergens may be culprit?

Authors:  Carlo Lombardi; Eleonora Savi; Erminia Ridolo; Giovanni Passalacqua; Giorgio Walter Canonica
Journal:  World Allergy Organ J       Date:  2017-01-06       Impact factor: 4.084

7.  Betamethasone prevents human rhinovirus- and cigarette smoke- induced loss of respiratory epithelial barrier function.

Authors:  Eva E Waltl; Regina Selb; Julia Eckl-Dorna; Christian A Mueller; Clarissa R Cabauatan; Thomas Eiwegger; Yvonne Resch-Marat; Katarzyna Niespodziana; Susanne Vrtala; Rudolf Valenta; Verena Niederberger
Journal:  Sci Rep       Date:  2018-06-26       Impact factor: 4.379

Review 8.  Type 2 immunity in asthma.

Authors:  Marco Caminati; Duy Le Pham; Diego Bagnasco; Giorgio Walter Canonica
Journal:  World Allergy Organ J       Date:  2018-06-26       Impact factor: 4.084

9.  Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab.

Authors:  Abhishek Kavati; Dominic Pilon; Benjamin Ortiz; Brandee Paknis; Ashok Vegesna; Bradd Schiffman; Maryia Zhdanava; Patrick Lefebvre; Brian Stone
Journal:  Allergy Rhinol (Providence)       Date:  2018-04-09

10.  Association of molds and metrological parameters to frequency of severe asthma exacerbation.

Authors:  Mona Al-Ahmad; Edin Jusufovic; Nermina Arifhodzic; Tito Rodriguez; Jasmina Nurkic
Journal:  Allergy Asthma Clin Immunol       Date:  2019-04-29       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.